Omega 3 Supplements Market Size, Share & Trends Analysis Report By Source (Fish, Krill, Algal), By Form (Tablets, Soft Gels, Capsules, Others), By End Use, By Functionality, By Distribution Channel, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days
Omega 3 Supplements Market Growth & Trends
The global omega 3 supplements market size is expected treach USD 12.89 billion by 2030, according ta new report by Grand View Research, Inc. It is expected texpand at a CAGR of 9.1% from 2025 t2030. The demand for omega-3 supplements is projected tbe driven by the growing adoption of the product tfulfill the daily nutritional requirements and maintain optimum health of organs by the geriatric population in developed economies, such as the U.S., Canada, the U.K., and France.
Furthermore, the outbreak of COVID-19 from the beginning of 2020 led tincreased consumer awareness regarding the significance of immunity and immunity-boosting products, which is expected tfuel the demand for various omega fatty acids products. Increasing incorporation of products in gummies form with novel flavor is expected tincrease product penetration among children in the coming years.
Docosahexaenoic acid (DHA) is an omega-3 fatty acid comprising over 93.0% of omega-3 fats in the retina and 97.0% in the human brain. Rising demand for DHA supplements for pregnant ladies owing tlack of adequate DHA in the diet is expected tdrive the market. Additionally, increasing demand for omega-3 DHA-rich supplements from non-lactating mothers is expected tpropel the product demand over the forecast period.
Rising chronic diseases such as strokes, arthritis, coronary heart diseases, and cancer are expected tpropel the demand for omega 3 supplements over the upcoming years. According tthe World Health Organization (WHO), over 14 million people between the ages of 30 and 70 die every year due tdistinguished chronic diseases. Rising government support tprovide consumers with low-cost preventive drugs is projected tpropel the demand for omega 3 supplements over the forecast period.
Omega 3 Supplements Market Report Highlights
Omega 3 Supplements Market Growth & Trends
The global omega 3 supplements market size is expected treach USD 12.89 billion by 2030, according ta new report by Grand View Research, Inc. It is expected texpand at a CAGR of 9.1% from 2025 t2030. The demand for omega-3 supplements is projected tbe driven by the growing adoption of the product tfulfill the daily nutritional requirements and maintain optimum health of organs by the geriatric population in developed economies, such as the U.S., Canada, the U.K., and France.
Furthermore, the outbreak of COVID-19 from the beginning of 2020 led tincreased consumer awareness regarding the significance of immunity and immunity-boosting products, which is expected tfuel the demand for various omega fatty acids products. Increasing incorporation of products in gummies form with novel flavor is expected tincrease product penetration among children in the coming years.
Docosahexaenoic acid (DHA) is an omega-3 fatty acid comprising over 93.0% of omega-3 fats in the retina and 97.0% in the human brain. Rising demand for DHA supplements for pregnant ladies owing tlack of adequate DHA in the diet is expected tdrive the market. Additionally, increasing demand for omega-3 DHA-rich supplements from non-lactating mothers is expected tpropel the product demand over the forecast period.
Rising chronic diseases such as strokes, arthritis, coronary heart diseases, and cancer are expected tpropel the demand for omega 3 supplements over the upcoming years. According tthe World Health Organization (WHO), over 14 million people between the ages of 30 and 70 die every year due tdistinguished chronic diseases. Rising government support tprovide consumers with low-cost preventive drugs is projected tpropel the demand for omega 3 supplements over the forecast period.
Omega 3 Supplements Market Report Highlights
- In terms of source, the krill oil-based omega 3 supplements are projected texpand at the fastest CAGR over the projected period on account of the growing demand for eicosapentaenoic acid (EPA) and DHA-based supplements among consumers globally
- On the basis of functionality, The cardiovascular health segment dominated the market with the largest revenue share in 2024. The growing prevalence of cardiovascular diseases as a result of the slow and inactive lifestyle, especially in the age group of 30 t40 years, and fluctuating dietary patterns are anticipated tspur the segment growth over the next few years
- The market in China is expected twitness significant growth over the upcoming years owing tthe propelling spending capacity of consumers. Easy online availability of these supplements in the country has alsstrengthened its demand in the country
- Strong mass channels of distribution, online sales, and a growing number of standalone mass facing brands by several companies, including Optimum Nutrition; Herbalife International of America, Inc.; Now Foods., and Amway are the key factors expected tfuel the demand for fish oil-based omega 3 supplements over the upcoming years
- In September 2020, Aker BioMarine launched a new support vessel at Yantai yard, China. The new vessel's launching has assured the stakeholders that the lockdown due tthe COVID-19 pandemic has not affected the company
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. OMEGA 3 SUPPLEMENTS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related Market Outlook
3.2. Industry Value Chain Analysis
3.2.1. Profit Margin Analysis (Industry-level)
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Market Opportunities
3.3.4. Market Challenges
3.4. Industry Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.5. Market Entry Strategies
CHAPTER 4. CONSUMER BEHAVIOR ANALYSIS
4.1. Demographic Analysis
4.2. Consumer Trends and Preferences
4.3. Factors Affecting Buying Decision
4.4. Consumer Product Adoption
4.5. Observations & Recommendations
CHAPTER 5. OMEGA 3 SUPPLEMENTS MARKET: SOURCE ESTIMATES & TREND ANALYSIS
5.1. Omega 3 Supplements Market, By Source: Key Takeaways
5.2. Source Movement Analysis & Market Share, 2024 & 2030
5.3. Market Estimates & Forecasts, By Source, 2018 - 2030 (USD Million)
5.3.1. Fish Oil
5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.2. Krill Oil
5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.3. Algal Oil
5.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.4. Others
5.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6. OMEGA 3 SUPPLEMENTS MARKET: FORM ESTIMATES & TREND ANALYSIS
6.1. Omega 3 Supplements Market, By Form: Key Takeaways
6.2. Form Movement Analysis & Market Share, 2024 & 2030
6.3. Market Estimates & Forecasts, By Form, 2018 - 2030 (USD Million)
6.3.1. Tablets
6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.2. Capsules
6.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.3. Soft Gels
6.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.4. Others
6.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. OMEGA 3 SUPPLEMENTS MARKET: FUNCTIONALITY ESTIMATES & TREND ANALYSIS
7.1. Omega 3 Supplements Market, By Functionality: Key Takeaways
7.2. Functionality Movement Analysis & Market Share, 2024 & 2030
7.3. Market Estimates & Forecasts, By Functionality, 2018 - 2030 (USD Million)
7.3.1. Cardiovascular Health
7.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.2. Brain, Nervous System & Mental Health
7.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.3. Eye Diseases
7.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.4. Diabetes
7.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.5. Others
7.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8. OMEGA 3 SUPPLEMENTS MARKET: END USE ESTIMATES & TREND ANALYSIS
8.1. Omega 3 Supplements Market, By End Use: Key Takeaways
8.2. End Use Movement Analysis & Market Share, 2024 & 2030
8.3. Market Estimates & Forecasts, by End Use, 2018 - 2030 (USD Million)
8.3.1. Adults
8.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.2. Geriatric
8.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.3. Pregnant Woman
8.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.4. Children
8.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.5. Infants
8.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9. OMEGA 3 SUPPLEMENTS MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
9.1. Omega 3 Supplements Market, By Distribution Channel: Key Takeaways
9.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030
9.3. Market Estimates & Forecasts, by Distribution Channel, 2018 - 2030 (USD Million)
9.3.1. OTC
9.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
9.3.1.2. Supermarkets/ Hypermarkets/Food Stores
9.3.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
9.3.1.3. Drug Stores & Pharmacies
9.3.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
9.3.1.4. Online Retailers
9.3.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
9.3.1.5. Others
9.3.1.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
9.3.2. Prescribed
9.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 10. OMEGA 3 SUPPLEMENTS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
10.1. Omega 3 Supplements Market: Regional Outlook
10.2. Regional Marketplaces: Key Takeaways
10.3. Market Estimates & Forecasts, by Region, 2018 - 2030 (USD Million)
10.3.1. North America
10.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.1.2. U.S.
10.3.1.2.1. Key country dynamics
10.3.1.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.1.3. Canada
10.3.1.3.1. Key country dynamics
10.3.1.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.1.4. Mexico
10.3.1.4.1. Key country dynamics
10.3.1.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2. Europe
10.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2.2. UK
10.3.2.2.1. Key country dynamics
10.3.2.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2.3. Germany
10.3.2.3.1. Key country dynamics
10.3.2.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2.4. France
10.3.2.4.1. Key country dynamics
10.3.2.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2.5. Italy
10.3.2.5.1. Key country dynamics
10.3.2.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2.6. Spain
10.3.2.6.1. Key country dynamics
10.3.2.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2.7. Norway
10.3.2.7.1. Key country dynamics
10.3.2.7.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2.8. Netherlands
10.3.2.8.1. Key country dynamics
10.3.2.8.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.3. Asia Pacific
10.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.3.2. China
10.3.3.2.1. Key country dynamics
10.3.3.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.3.3. India
10.3.3.3.1. Key country dynamics
10.3.3.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.3.4. Japan
10.3.3.4.1. Key country dynamics
10.3.3.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.3.5. Australia
10.3.3.5.1. Key country dynamics
10.3.3.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.3.6. New Zealand
10.3.3.6.1. Key country dynamics
10.3.3.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.4. Latin America
10.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.4.2. Brazil
10.3.4.2.1. Key country dynamics
10.3.4.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.4.3. Argentina
10.3.4.3.1. Key country dynamics
10.3.4.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.5. Middle East & Africa
10.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.5.2. UAE
10.3.5.2.1. Key country dynamics
10.3.5.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 11. OMEGA 3 SUPPLEMENTS MARKET: COMPETITIVE ANALYSIS
11.1. Recent Developments & Impact Analysis, by Key Market Participants
11.2. Company Categorization
11.3. Participant’s Overview
11.4. Financial Performance
11.5. Product Benchmarking
11.6. Company Market Share Analysis, 2024 (%)
11.7. Company Heat Map Analysis
11.8. Strategy Mapping
11.9. Company Profiles
11.9.1. Nordic Naturals
11.9.1.1. Company Overview
11.9.1.2. Financial Performance
11.9.1.3. Product Portfolios
11.9.1.4. Strategic Initiatives
11.9.2. NutriGold
11.9.2.1. Company Overview
11.9.2.2. Financial Performance
11.9.2.3. Product Portfolios
11.9.2.4. Strategic Initiatives
11.9.3. Reckitt Benckiser Group PLC
11.9.3.1. Company Overview
11.9.3.2. Financial Performance
11.9.3.3. Product Portfolios
11.9.3.4. Strategic Initiatives
11.9.4. Pharma Nord Inc.
11.9.4.1. Company Overview
11.9.4.2. Financial Performance
11.9.4.3. Product Portfolios
11.9.4.4. Strategic Initiatives
11.9.5. i-Health, Inc.
11.9.5.1. Company Overview
11.9.5.2. Financial Performance
11.9.5.3. Product Portfolios
11.9.5.4. Strategic Initiatives
11.9.6. AKER BIOMARINE
11.9.6.1. Company Overview
11.9.6.2. Financial Performance
11.9.6.3. Product Portfolios
11.9.6.4. Strategic Initiatives
11.9.7. Luhua Biomarine (Shandong) Co., Ltd
11.9.7.1. Company Overview
11.9.7.2. Financial Performance
11.9.7.3. Product Portfolios
11.9.7.4. Strategic Initiatives
11.9.8. Pharmavite
11.9.8.1. Company Overview
11.9.8.2. Financial Performance
11.9.8.3. Product Portfolios
11.9.8.4. Strategic Initiatives
11.9.9. KD Pharma Group SA
11.9.9.1. Company Overview
11.9.9.2. Financial Performance
11.9.9.3. Product Portfolios
11.9.9.4. Strategic Initiatives
11.9.10. NOW Foods
11.9.10.1. Company Overview
11.9.10.2. Financial Performance
11.9.10.3. Product Portfolios
11.9.10.4. Strategic Initiatives
11.9.11. GSK plc
11.9.11.1. Company Overview
11.9.11.2. Financial Performance
11.9.11.3. Product Portfolios
11.9.11.4. Strategic Initiatives
11.9.12. Nature's Bounty
11.9.12.1. Company Overview
11.9.12.2. Financial Performance
11.9.12.3. Product Portfolios
11.9.12.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. OMEGA 3 SUPPLEMENTS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related Market Outlook
3.2. Industry Value Chain Analysis
3.2.1. Profit Margin Analysis (Industry-level)
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Market Opportunities
3.3.4. Market Challenges
3.4. Industry Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.5. Market Entry Strategies
CHAPTER 4. CONSUMER BEHAVIOR ANALYSIS
4.1. Demographic Analysis
4.2. Consumer Trends and Preferences
4.3. Factors Affecting Buying Decision
4.4. Consumer Product Adoption
4.5. Observations & Recommendations
CHAPTER 5. OMEGA 3 SUPPLEMENTS MARKET: SOURCE ESTIMATES & TREND ANALYSIS
5.1. Omega 3 Supplements Market, By Source: Key Takeaways
5.2. Source Movement Analysis & Market Share, 2024 & 2030
5.3. Market Estimates & Forecasts, By Source, 2018 - 2030 (USD Million)
5.3.1. Fish Oil
5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.2. Krill Oil
5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.3. Algal Oil
5.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.4. Others
5.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6. OMEGA 3 SUPPLEMENTS MARKET: FORM ESTIMATES & TREND ANALYSIS
6.1. Omega 3 Supplements Market, By Form: Key Takeaways
6.2. Form Movement Analysis & Market Share, 2024 & 2030
6.3. Market Estimates & Forecasts, By Form, 2018 - 2030 (USD Million)
6.3.1. Tablets
6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.2. Capsules
6.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.3. Soft Gels
6.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.4. Others
6.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. OMEGA 3 SUPPLEMENTS MARKET: FUNCTIONALITY ESTIMATES & TREND ANALYSIS
7.1. Omega 3 Supplements Market, By Functionality: Key Takeaways
7.2. Functionality Movement Analysis & Market Share, 2024 & 2030
7.3. Market Estimates & Forecasts, By Functionality, 2018 - 2030 (USD Million)
7.3.1. Cardiovascular Health
7.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.2. Brain, Nervous System & Mental Health
7.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.3. Eye Diseases
7.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.4. Diabetes
7.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.5. Others
7.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8. OMEGA 3 SUPPLEMENTS MARKET: END USE ESTIMATES & TREND ANALYSIS
8.1. Omega 3 Supplements Market, By End Use: Key Takeaways
8.2. End Use Movement Analysis & Market Share, 2024 & 2030
8.3. Market Estimates & Forecasts, by End Use, 2018 - 2030 (USD Million)
8.3.1. Adults
8.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.2. Geriatric
8.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.3. Pregnant Woman
8.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.4. Children
8.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.5. Infants
8.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9. OMEGA 3 SUPPLEMENTS MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
9.1. Omega 3 Supplements Market, By Distribution Channel: Key Takeaways
9.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030
9.3. Market Estimates & Forecasts, by Distribution Channel, 2018 - 2030 (USD Million)
9.3.1. OTC
9.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
9.3.1.2. Supermarkets/ Hypermarkets/Food Stores
9.3.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
9.3.1.3. Drug Stores & Pharmacies
9.3.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
9.3.1.4. Online Retailers
9.3.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
9.3.1.5. Others
9.3.1.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
9.3.2. Prescribed
9.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 10. OMEGA 3 SUPPLEMENTS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
10.1. Omega 3 Supplements Market: Regional Outlook
10.2. Regional Marketplaces: Key Takeaways
10.3. Market Estimates & Forecasts, by Region, 2018 - 2030 (USD Million)
10.3.1. North America
10.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.1.2. U.S.
10.3.1.2.1. Key country dynamics
10.3.1.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.1.3. Canada
10.3.1.3.1. Key country dynamics
10.3.1.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.1.4. Mexico
10.3.1.4.1. Key country dynamics
10.3.1.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2. Europe
10.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2.2. UK
10.3.2.2.1. Key country dynamics
10.3.2.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2.3. Germany
10.3.2.3.1. Key country dynamics
10.3.2.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2.4. France
10.3.2.4.1. Key country dynamics
10.3.2.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2.5. Italy
10.3.2.5.1. Key country dynamics
10.3.2.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2.6. Spain
10.3.2.6.1. Key country dynamics
10.3.2.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2.7. Norway
10.3.2.7.1. Key country dynamics
10.3.2.7.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.2.8. Netherlands
10.3.2.8.1. Key country dynamics
10.3.2.8.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.3. Asia Pacific
10.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.3.2. China
10.3.3.2.1. Key country dynamics
10.3.3.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.3.3. India
10.3.3.3.1. Key country dynamics
10.3.3.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.3.4. Japan
10.3.3.4.1. Key country dynamics
10.3.3.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.3.5. Australia
10.3.3.5.1. Key country dynamics
10.3.3.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.3.6. New Zealand
10.3.3.6.1. Key country dynamics
10.3.3.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.4. Latin America
10.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.4.2. Brazil
10.3.4.2.1. Key country dynamics
10.3.4.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.4.3. Argentina
10.3.4.3.1. Key country dynamics
10.3.4.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.5. Middle East & Africa
10.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
10.3.5.2. UAE
10.3.5.2.1. Key country dynamics
10.3.5.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 11. OMEGA 3 SUPPLEMENTS MARKET: COMPETITIVE ANALYSIS
11.1. Recent Developments & Impact Analysis, by Key Market Participants
11.2. Company Categorization
11.3. Participant’s Overview
11.4. Financial Performance
11.5. Product Benchmarking
11.6. Company Market Share Analysis, 2024 (%)
11.7. Company Heat Map Analysis
11.8. Strategy Mapping
11.9. Company Profiles
11.9.1. Nordic Naturals
11.9.1.1. Company Overview
11.9.1.2. Financial Performance
11.9.1.3. Product Portfolios
11.9.1.4. Strategic Initiatives
11.9.2. NutriGold
11.9.2.1. Company Overview
11.9.2.2. Financial Performance
11.9.2.3. Product Portfolios
11.9.2.4. Strategic Initiatives
11.9.3. Reckitt Benckiser Group PLC
11.9.3.1. Company Overview
11.9.3.2. Financial Performance
11.9.3.3. Product Portfolios
11.9.3.4. Strategic Initiatives
11.9.4. Pharma Nord Inc.
11.9.4.1. Company Overview
11.9.4.2. Financial Performance
11.9.4.3. Product Portfolios
11.9.4.4. Strategic Initiatives
11.9.5. i-Health, Inc.
11.9.5.1. Company Overview
11.9.5.2. Financial Performance
11.9.5.3. Product Portfolios
11.9.5.4. Strategic Initiatives
11.9.6. AKER BIOMARINE
11.9.6.1. Company Overview
11.9.6.2. Financial Performance
11.9.6.3. Product Portfolios
11.9.6.4. Strategic Initiatives
11.9.7. Luhua Biomarine (Shandong) Co., Ltd
11.9.7.1. Company Overview
11.9.7.2. Financial Performance
11.9.7.3. Product Portfolios
11.9.7.4. Strategic Initiatives
11.9.8. Pharmavite
11.9.8.1. Company Overview
11.9.8.2. Financial Performance
11.9.8.3. Product Portfolios
11.9.8.4. Strategic Initiatives
11.9.9. KD Pharma Group SA
11.9.9.1. Company Overview
11.9.9.2. Financial Performance
11.9.9.3. Product Portfolios
11.9.9.4. Strategic Initiatives
11.9.10. NOW Foods
11.9.10.1. Company Overview
11.9.10.2. Financial Performance
11.9.10.3. Product Portfolios
11.9.10.4. Strategic Initiatives
11.9.11. GSK plc
11.9.11.1. Company Overview
11.9.11.2. Financial Performance
11.9.11.3. Product Portfolios
11.9.11.4. Strategic Initiatives
11.9.12. Nature's Bounty
11.9.12.1. Company Overview
11.9.12.2. Financial Performance
11.9.12.3. Product Portfolios
11.9.12.4. Strategic Initiatives
